Integra LifeSciencesIART
那斯達克 · USD
9.07
-0.54
(-5.62%)
盤中 03/13 02:49 (UTC+8)
03/13 02:49 (UTC+8)
Integra LifeSciencesIART
9.07
-0.54
(-5.62%)
財務數據
損益表
- 3.82
- 3.97
- 3.69
- 4.18
- 3.81
- 4.43
- 3.83
- 4.16
- 4.02
- 4.35
- 0.30
- 3.82
- -7.09
- 13.37
- -8.93
- 16.23
- -13.55
- 8.61
- -3.26
- 8.17
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 434,925 | 402,062 | 415,605 | 382,653 | 442,646 | 380,834 | 418,175 | 368,872 | 397,039 | 382,421 |
營業成本 | 214,060 | 195,071 | 206,273 | 188,221 | 193,574 | 180,596 | 192,258 | 162,038 | 170,546 | 164,076 |
營業毛利 | 220,865 | 206,991 | 209,332 | 194,432 | 249,072 | 200,238 | 225,917 | 206,834 | 226,493 | 218,345 |
營業費用 | 197,825 | 195,230 | 722,006 | - | - | - | - | 202,870 | 190,446 | 191,752 |
研發費用 | 24,790 | 22,456 | 26,997 | 24,728 | 31,210 | 27,435 | 29,767 | 26,965 | 24,284 | 26,596 |
推銷及管理費用 | 169,267 | 169,046 | 179,890 | 181,497 | 178,520 | 177,193 | 195,472 | 165,798 | 163,128 | 161,948 |
非經常性項目費用 | - | - | 511,365 | - | - | - | - | - | - | - |
其他營業費用 | 3,768 | 3,728 | 3,754 | 3,704 | 3,715 | 3,761 | 3,707 | 10,107 | 3,034 | 3,208 |
營業利益 | 23,040 | 11,761 | -512,674 | -15,497 | 35,627 | -8,151 | -3,029 | 3,964 | 36,047 | 26,593 |
其他收入及費用 | 4,943 | 4,140 | 2,764 | 4,276 | 5,898 | 7,161 | 6,495 | 4,430 | 6,562 | 5,078 |
利息費用 | 23,673 | 22,725 | 21,042 | 18,815 | 18,984 | 19,373 | 18,651 | 13,624 | 13,751 | 13,062 |
稅前純益 | 4,310 | -6,824 | -530,952 | -30,036 | 22,541 | -20,363 | -15,185 | -5,230 | 28,858 | 18,609 |
所得稅 | 6,014 | -1,420 | -46,879 | -4,743 | 3,106 | -9,667 | -2,783 | -1,949 | 9,024 | -888 |
稅後純益 | -1,704 | -5,404 | -484,073 | -25,293 | 19,435 | -10,696 | -12,402 | -3,281 | 19,834 | 19,497 |
基本每股稅後盈餘(元) | -0.13 | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.25 |
稀釋每股稅後盈餘(元) | -0.02 | -0.07 | -6.32 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 |
基本平均股數(千股) | 74302.00 | 76753.00 | 76695.00 | 76463.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 | 78169.00 | 79112.00 |
稀釋平均股數(千股) | 73855.00 | 76753.00 | 76695.00 | 76463.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 | 78169.00 | 79811.00 |
還原基本每股稅後盈餘(元) | -0.13 | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.25 |
還原稀釋每股稅後盈餘(元) | -0.02 | -0.07 | -6.32 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 | 0.25 | 0.24 |
還原基本平均股數(千股) | 74,302 | 76,753 | 76,695 | 76,463 | 77,164 | 77,134 | 77,583 | 78,749 | 78,169 | 79,112 |
還原稀釋平均股數(千股) | 73,855 | 76,753 | 76,695 | 76,463 | 77,164 | 77,134 | 77,583 | 78,749 | 78,169 | 79,811 |
EBITDA(千元) | 67,428 | 55,738 | -470,328 | 27,352 | 80,514 | 36,306 | 41,703 | 40,358 | 75,027 | 63,646 |